| Literature DB >> 26789921 |
Nicholas S Heaton1, Natasha Moshkina2, Romain Fenouil3, Thomas J Gardner1, Sebastian Aguirre1, Priya S Shah4, Nan Zhao2, Lara Manganaro1, Judd F Hultquist4, Justine Noel2, David Sachs3, Jennifer Hamilton1, Paul E Leon1, Amit Chawdury5, Shashank Tripathi1, Camilla Melegari2, Laura Campisi2, Rong Hai1, Giorgi Metreveli2, Andrea V Gamarnik6, Adolfo García-Sastre7, Benjamin Greenbaum5, Viviana Simon2, Ana Fernandez-Sesma2, Nevan J Krogan4, Lubbertus C F Mulder2, Harm van Bakel3, Domenico Tortorella1, Jack Taunton4, Peter Palese1, Ivan Marazzi8.
Abstract
Viruses are obligate parasites and thus require the machinery of the host cell to replicate. Inhibition of host factors co-opted during active infection is a strategy hosts use to suppress viral replication and a potential pan-antiviral therapy. To define the cellular proteins and processes required for a virus during infection is thus crucial to understanding the mechanisms of virally induced disease. In this report, we generated fully infectious tagged influenza viruses and used infection-based proteomics to identify pivotal arms of cellular signaling required for influenza virus growth and infectivity. Using mathematical modeling and genetic and pharmacologic approaches, we revealed that modulation of Sec61-mediated cotranslational translocation selectively impaired glycoprotein proteostasis of influenza as well as HIV and dengue viruses and led to inhibition of viral growth and infectivity. Thus, by studying virus-human protein-protein interactions in the context of active replication, we have identified targetable host factors for broad-spectrum antiviral therapies.Entities:
Mesh:
Year: 2016 PMID: 26789921 PMCID: PMC4878455 DOI: 10.1016/j.immuni.2015.12.017
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745